Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|November 1, 1993
Incapacitating autonomic neuropathy precipitated by taxolS M Jerian, G A Sarosy, C J Link, et al.
Investigational New Drugs|January 1, 1995
Cutaneous manifestations of Taxol therapyC J Link, G A Sarosy, E C Kohn, et al.
Blood|March 1, 1994
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapyC J Link, A Bicher, E C Kohn, et al.
Cancer|November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancerJ D Shapiro, M L Rothenberg, G A Sarosy, et al.
British Journal of Cancer|January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicityJ-M Lee, G A Sarosy, C M Annunziata, et al.
Cancer Research|October 1, 1986
Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumorsG A Sarosy, T D Brown, D D Von Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulationsE C Kohn, W D Figg, G A Sarosy, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U)G R Weiss, G A Sarosy, T D Shenkenberg, et al.
Gynecologic Oncology|August 1, 1996
A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancerE C Kohn, G A Sarosy, P Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interactionE C Kohn, E Reed, G A Sarosy, et al.
Pageof 1